최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal for immunotherapy of cancer, v.9 no.6, 2021년, pp.e002603 -
Kim, Byung-Seok (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) , Kuen, Da-Sol (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) , Koh, Choong-Hyun (Lab of Immune Regulation, Research Institute of Pharmaceutical Sciences, College of Pharmacy , Seoul National University , Seoul , South Korea) , Kim, Hyung-Don (Graduate School of Medical Science and Engineering , Korea Advanced Institute of Science and Technology , Daejeon , South Korea) , Chang, Seon Hee (Department of Immunology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA) , Kim, Sehui (Department of Pathology, Seoul National University Hospital , Seoul National University College of Medicine , Seoul , South Korea) , Jeon, Yoon Kyung (Department of Pa) , Park, Young-Jun , Choi, Garam , Kim, Jiyeon , Kang, Keon Wook , Kim, Hye Young , Kang, Suk-Jo , Hwang, Shin , Shin, Eui-Cheol , Kang, Chang-Yuil , Dong, Chen , Chung, Yeonseok
BackgroundMultiple types of immune cells producing IL-17 are found in the tumor microenvironment. However, their roles in tumor progression and exhaustion of CD8+ tumor-infiltrating lymphocytes (TILs) remain unclear.MethodsTo determine the role of type 17 immunity in tumor, we investigated the growt...
1 Binnewies M , Roberts EW , Kersten K , et al . Understanding the tumor immune microenvironment (time) for effective therapy . Nat Med 2018 ; 24 : 541 – 50 . 10.1038/s41591-018-0014-x 29686425
2 Gabrilovich DI . Myeloid-derived suppressor cells . Cancer Immunol Res 2017 ; 5 : 3 – 8 . 10.1158/2326-6066.CIR-16-0297 28052991
3 Tanaka A , Sakaguchi S . Targeting Treg cells in cancer immunotherapy . Eur J Immunol 2019 ; 49 : 1140 – 6 . 10.1002/eji.201847659 31257581
4 Zhao J , Chen X , Herjan T , et al . The role of interleukin-17 in tumor development and progression . J Exp Med 2020 ; 217 . 10.1084/jem.20190297 . [Epub ahead of print: 06 Jan 2020 ].
5 Langowski JL , Zhang X , Wu L , et al . IL-23 promotes tumour incidence and growth . Nature 2006 ; 442 : 461 – 5 . 10.1038/nature04808 16688182
6 Purwar R , Schlapbach C , Xiao S , et al . Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells . Nat Med 2012 ; 18 : 1248 – 53 . 10.1038/nm.2856 22772464
7 Chang SH , Mirabolfathinejad SG , Katta H , et al . T helper 17 cells play a critical pathogenic role in lung cancer . Proc Natl Acad Sci U S A 2014 ; 111 : 5664 – 9 . 10.1073/pnas.1319051111 24706787
8 Numasaki M , Fukushi J-ichi , Ono M , et al . Interleukin-17 promotes angiogenesis and tumor growth . Blood 2003 ; 101 : 2620 – 7 . 10.1182/blood-2002-05-1461 12411307
9 Wang S , Li Zhi'an , Hu G . Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis . Oncotarget 2017 ; 8 : 66382 – 91 . 10.18632/oncotarget.18807 29029520
10 Chen J-gao , Xia J-chuan , Liang X-ting , et al . Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients . Int J Biol Sci 2011 ; 7 : 53 – 60 . 10.7150/ijbs.7.53 21234303
11 Han Y , Ye A , Bi L , et al . Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia . Cancer Sci 2014 ; 105 : 933 – 42 . 10.1111/cas.12459 24890519
12 Martin-Orozco N , Muranski P , Chung Y , et al . T helper 17 cells promote cytotoxic T cell activation in tumor immunity . Immunity 2009 ; 31 : 787 – 98 . 10.1016/j.immuni.2009.09.014 19879162
13 Yu Y , Cho H-I , Wang D , et al . Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms . J Immunol 2013 ; 190 : 1873 – 81 . 10.4049/jimmunol.1201989 23315072
14 Hu X , Liu X , Moisan J , et al . Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity . Oncoimmunology 2016 ; 5 : e1254854 . 10.1080/2162402X.2016.1254854 28123897
15 Kryczek I , Wei S , Szeliga W , et al . Endogenous IL-17 contributes to reduced tumor growth and metastasis . Blood 2009 ; 114 : 357 – 9 . 10.1182/blood-2008-09-177360 19289853
16 Jain P , Javdan M , Feger FK , et al . Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance . Haematologica 2012 ; 97 : 599 – 607 . 10.3324/haematol.2011.047316 22058222
17 Punt S , van Vliet ME , Spaans VM , et al . FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma . Cancer Immunol Immunother 2015 ; 64 : 745 – 53 . 10.1007/s00262-015-1678-4 25795131
18 McLane LM , Abdel-Hakeem MS , Wherry EJ . CD8 T cell exhaustion during chronic viral infection and cancer . Annu Rev Immunol 2019 ; 37 : 457 – 95 . 10.1146/annurev-immunol-041015-055318 30676822
19 Miller BC , Sen DR , Al Abosy R , et al . Subsets of exhausted CD8 + T cells differentially mediate tumor control and respond to checkpoint blockade . Nat Immunol 2019 ; 20 : 326 – 36 . 10.1038/s41590-019-0312-6 30778252
20 Siddiqui I , Schaeuble K , Chennupati V , et al . Intratumoral Tcf1 + PD-1 + CD8 + T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy . Immunity 2019 ; 50 : e10 : 195 – 211 . 10.1016/j.immuni.2018.12.021
21 Kim K , Park S , Park SY , et al . Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer . Genome Med 2020 ; 12 : 22 . 10.1186/s13073-020-00722-9 32111241
22 Wherry EJ , Kurachi M . Molecular and cellular insights into T cell exhaustion . Nat Rev Immunol 2015 ; 15 : 486 – 99 . 10.1038/nri3862 26205583
23 Kim JM , Rasmussen JP , Rudensky AY . Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice . Nat Immunol 2007 ; 8 : 191 – 7 . 10.1038/ni1428 17136045
24 Song B , Lee J-M , Park Y-J , et al . Differentiation of c-Kit + CD24 + natural killer cells into myeloid cells in a GATA-2-dependent manner . Faseb J 2020 ; 34 : 4462 – 81 . 10.1096/fj.201902662R 31989715
25 Cho Y , Kwon D , Kang S-J . The cooperative role of CD326 + and CD11b + dendritic cell subsets for a hapten-induced Th2 differentiation . J Immunol 2017 ; 199 : 3137 – 46 . 10.4049/jimmunol.1601262 28972093
26 Kim H-D , Song G-W , Park S , et al . Association between expression level of PD1 by tumor-infiltrating CD8 + T cells and features of hepatocellular carcinoma . Gastroenterology 2018 ; 155 : e17 : 1936 – 50 . 10.1053/j.gastro.2018.08.030
27 Park Y-J , Ryu H , Choi G , et al . IL-27 confers a protumorigenic activity of regulatory T cells via CD39 . Proc Natl Acad Sci U S A 2019 ; 116 : 3106 – 11 . 10.1073/pnas.1810254116 30718407
28 Ciofani M , Madar A , Galan C , et al . A validated regulatory network for Th17 cell specification . Cell 2012 ; 151 : 289 – 303 . 10.1016/j.cell.2012.09.016 23021777
29 Doering TA , Crawford A , Angelosanto JM , et al . Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory . Immunity 2012 ; 37 : 1130 – 44 . 10.1016/j.immuni.2012.08.021 23159438
30 Singer M , Wang C , Cong L , et al . A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells . Cell 2016 ; 166 : 1500 – 11 . 10.1016/j.cell.2016.08.052 27610572
31 Ahrends T , Spanjaard A , Pilzecker B , et al . CD4 + T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness . Immunity 2017 ; 47 : 848 – 61 . 10.1016/j.immuni.2017.10.009 29126798
32 Amsen D , van Gisbergen KPJM , Hombrink P , et al . Tissue-Resident memory T cells at the center of immunity to solid tumors . Nat Immunol 2018 ; 19 : 538 – 46 . 10.1038/s41590-018-0114-2 29777219
33 Lee YK , Turner H , Maynard CL , et al . Late developmental plasticity in the T helper 17 lineage . Immunity 2009 ; 30 : 92 – 107 . 10.1016/j.immuni.2008.11.005 19119024
34 Yen H-R , Harris TJ , Wada S , et al . Tc17 CD8 T cells: functional plasticity and subset diversity . J Immunol 2009 ; 183 : 7161 – 8 . 10.4049/jimmunol.0900368 19917680
35 Kim B-S , Park Y-J , Chung Y . Targeting IL-17 in autoimmunity and inflammation . Arch Pharm Res 2016 ; 39 : 1537 – 47 . 10.1007/s12272-016-0823-8 27576555
36 Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming . Nat Rev Immunol 2008 ; 8 : 337 – 48 . 10.1038/nri2295 18408735
37 Codarri L , Gyülvészi G , Tosevski V , et al . Rorγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation . Nat Immunol 2011 ; 12 : 560 – 7 . 10.1038/ni.2027 21516112
38 Ivanov II , McKenzie BS , Zhou L , et al . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells . Cell 2006 ; 126 : 1121 – 33 . 10.1016/j.cell.2006.07.035 16990136
39 Xu T , Wang X , Zhong B , et al . Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma T protein . J Biol Chem 2011 ; 286 : 22707 – 10 . 10.1074/jbc.C111.250407 21566134
40 Llosa NJ , Luber B , Tam AJ , et al . Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors . Clin Cancer Res 2019 ; 25 : 5250 – 9 . 10.1158/1078-0432.CCR-19-0114 31061070
41 Gopalakrishnan V , Spencer CN , Nezi L , et al . Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients . Science 2018 ; 359 : 97 – 103 . 10.1126/science.aan4236 29097493
42 Nagaoka K , Shirai M , Taniguchi K , et al . Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy . J Immunother Cancer 2020 ; 8 : e001358 . 10.1136/jitc-2020-001358 33093158
43 Liu C , Liu R , Wang B , et al . Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer . J Immunother Cancer 2021 ; 9 . 10.1136/jitc-2020-001895
44 Kong X , Sun R , Chen Y , et al . γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance . J Immunol 2014 ; 193 : 1645 – 53 . 10.4049/jimmunol.1303432 25015833
45 Tao J , Han D , Gao S , et al . CD8 + T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal-9 pathway . J Cell Mol Med 2020 ; 24 : 1046 – 58 . 10.1111/jcmm.14825 31756785
46 Tosello Boari J , Araujo Furlan CL , Fiocca Vernengo F , et al . IL-17RA-signaling modulates CD8+ T cell survival and exhaustion during Trypanosoma cruzi infection . Front Immunol 2018 ; 9 : 2347 . 10.3389/fimmu.2018.02347 30364284
47 Zander R , Schauder D , Xin G , et al . CD4 + T cell help is required for the formation of a cytolytic CD8 + T cell subset that protects against chronic infection and cancer . Immunity 2019 ; 51 : 1028 – 42 . 10.1016/j.immuni.2019.10.009 31810883
48 Hudson WH , Gensheimer J , Hashimoto M , et al . Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1 + stem-like CD8 + T cells during chronic infection . Immunity 2019 ; 51 : 1043 – 58 . 10.1016/j.immuni.2019.11.002 31810882
49 Ueha S , Yokochi S , Ishiwata Y , et al . Robust antitumor effects of combined anti-CD4-depleting antibody and anti-PD-1/PD-L1 immune checkpoint antibody treatment in mice . Cancer Immunol Res 2015 ; 3 : 631 – 40 . 10.1158/2326-6066.CIR-14-0190 25711759
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.